Skip to content

Establishment of identification criteria for asthenospermia (kidney deficiency and liver depression syndrome) and a multi-center randomized controlled study of Jin Gui Yu lin formula

Establishment of identification criteria for asthenospermia (kidney deficiency and liver depression syndrome) and a multi-center randomized controlled study of Jin Gui Yu lin formula

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001115
Enrollment
Unknown
Registered
2025-06-04
Start date
2025-04-03
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthenospermia

Interventions

control group:Control group: Levocanidin Oral Solution
Test group:Test group: Golden Turtle Yulin Formula

Sponsors

Xiyuan Hospital China Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
22 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of Western medicine; 2) Meet the Chinese medicine diagnostic criteria; 3)Male patients aged 22 years = age = 45 years; 4) Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1)Those with acute infection of the genitourinary tract; (2) Those with moderate or severe varicocele; (3)Abnormal sex hormone six; (4) Those who are unable to complete sexual intercourse due to sexual dysfunction such as erectile dysfunction retrograde ejaculation and abnormal ejaculation; (5)Those who are allergic to therapeutic drugs; (6) People with bad habits that affect semen quality (including frequent sauna steaming and washing long-term alcoholics etc.); (7) Those who take antitumor drugs antiepileptic and other drugs that affect sperm vitality; (8) Combined cardiovascular hematopoietic system liver and kidney diseases and other serious diseases; (9)Patients with family genetic diseases. Those who meet any of the above nine items will meet the exclusion criteria and will not be included in this study.

Design outcomes

Primary

MeasureTime frame
Progressive motility;

Secondary

MeasureTime frame
Chinese Medicine Symptom Score;conception rate;semen volume;Total Sperm Viability;spermatozoa;

Countries

China

Contacts

Public ContactJun Guo

Xiyuan Hospital China Academy of Traditional Chinese Medicine

guojun1126@126.com+86 139 1127 2060

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026